Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
NEO · NASDAQ · Health Care Services
$14.82−0.27 (−1.79%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
NeoGenomics Laboratories, Inc. (NEO) · oqro.io/stocks/NEO · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Politician trade (House) · Transaction Aug 7, 2026 · Disclosed Sep 10, 2026
Disclosed purchase of NEO — reported range $1,001 - $15,000SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bridgewater Associates no longer reported NEO for Q2 2026SourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Samlyn Capital, LLC disclosed a reduced position in NEO for Q2 2026SourceFederal contract · Signed Jun 17, 2026 · Updated Jun 17, 2026
Department of Veterans Affairs awarded NEOGENOMICS INC: $494K obligated to dateSourceFederal contract · Signed Jun 11, 2026 · Updated Jun 11, 2026
Department of Veterans Affairs awarded NEOGENOMICS INC: $100K obligated to dateSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 22, 2026
Segall Bryant & Hamill, LLC disclosed a reduced position in NEO for Q1 2026SourceFederal contract · Signed May 22, 2026 · Updated May 22, 2026
Department of Health and Human Services awarded NEOGENOMICS INC: $402K obligated to dateSourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Bridgewater Associates disclosed a new position in NEO for Q1 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Samlyn Capital, LLC disclosed an increased position in NEO for Q1 2026Fund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Samlyn Capital, LLC disclosed a new position in NEO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 17, 2026
Deerfield Management Company, L.P. no longer reported NEO for Q4 2025SourceFund moves · Holdings as of Dec 31, 2025 (Q4 2025) · Filed Feb 13, 2026
Segall Bryant & Hamill, LLC disclosed a reduced position in NEO for Q4 2025SourceFederal contract · Signed Feb 4, 2026 · Updated Feb 4, 2026
Department of Veterans Affairs awarded NEOGENOMICS INC: $500K obligated to dateFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Deerfield Management Company, L.P. disclosed an increased position in NEO for Q3 2025SourceFederal contract · Signed Oct 10, 2025 · Updated Oct 10, 2025
Department of Veterans Affairs awarded NEOGENOMICS INC: $2.79M obligated to dateSourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Deerfield Management Company, L.P. disclosed a new position in NEO for Q2 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Bellevue Group AG disclosed a reduced position in NEO for Q2 2025SourceInsider trade · Traded Aug 6, 2025 · Filed Aug 6, 2025
CEO purchased ~$100K of NEO shares in the open marketSourceInsider trade · Traded Aug 6, 2025 · Filed Aug 6, 2025
CFO purchased ~$112K of NEO shares in the open marketSourcePolitician trade (House) · Transaction May 7, 2025 · Disclosed Jun 6, 2025
Disclosed purchase of NEO — reported range $1,001 - $15,000SourceInsider trade · Traded May 27, 2025 · Filed May 28, 2025
Director purchased ~$38K of NEO shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
Oberweis Asset Management Inc no longer reported NEO for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 14, 2025
Bridgewater Associates no longer reported NEO for Q1 2025SourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 14, 2025
Bellevue Group AG disclosed an increased position in NEO for Q1 2025SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Oberweis Asset Management Inc disclosed an increased position in NEO for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 14, 2025
Bellevue Group AG disclosed a reduced position in NEO for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 13, 2025
Bridgewater Associates disclosed a reduced position in NEO for Q4 2024SourceFund moves · Holdings as of Dec 31, 2024 (Q4 2024) · Filed Feb 11, 2025
Segall Bryant & Hamill, LLC disclosed an increased position in NEO for Q4 2024Insider trade · Traded Nov 15, 2024 · Filed Nov 19, 2024
Officer sold ~$79K of NEO shares in the open marketSourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Bellevue Group AG disclosed an increased position in NEO for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 14, 2024
Oberweis Asset Management Inc disclosed an increased position in NEO for Q3 2024SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 13, 2024
Bridgewater Associates disclosed a reduced position in NEO for Q3 2024Politician trade (House) · Transaction Mar 30, 2022 · Disclosed Apr 25, 2022
Disclosed sale of NEO — reported range $1,001 - $15,000SourcePolitician trade (House) · Transaction Dec 30, 2021 · Disclosed Jan 8, 2022
Disclosed purchase of NEO — reported range $15,001 - $50,000SourcePolitician trade (House) · Transaction Nov 9, 2021 · Disclosed Nov 14, 2021
Disclosed sale of NEO — reported range $1,001 - $15,000SourceFederal contract · Signed Apr 24, 2026 · Updated May 4, 2026
Department of Veterans Affairs awarded NEOGENOMICS INC: $644K obligated to dateSourceFederal contract · Signed Oct 23, 2025 · Updated Feb 1, 2026
Department of Veterans Affairs awarded NEOGENOMICS INC: $325K obligated to dateSourceInsider trade · Traded May 12, 2025 · Filed May 13, 2025
Officer purchased ~$49K of NEO shares in the open marketSourceInsider trade · Traded May 7, 2025 · Filed May 9, 2025
Director purchased ~$31K of NEO shares in the open marketSourceInsider trade · Traded May 9, 2025 · Filed May 9, 2025
Director purchased ~$57K of NEO shares in the open marketSourceInsider trade · Traded May 6, 2025 · Filed May 8, 2025
CEO purchased ~$149K of NEO shares in the open marketSourceInsider trade · Traded May 5, 2025 · Filed May 7, 2025
Director purchased ~$35K of NEO shares in the open marketSourceInsider trade · Traded May 5, 2025 · Filed May 7, 2025
Director purchased ~$76K of NEO shares in the open marketSourceFund moves · Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 2, 2025
Segall Bryant & Hamill, LLC disclosed an increased position in NEO for Q1 2025SourceFund moves · Holdings as of Sep 30, 2024 (Q3 2024) · Filed Nov 8, 2024
Segall Bryant & Hamill, LLC disclosed an increased position in NEO for Q3 2024Source